These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38045158)

  • 1. Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening.
    Hsu CJ; Chen CH; Chen WT; Liu PC; Chang TY; Lin MH; Chen CC; Chen HY; Huang CH; Cheng YH; Sun JR
    Heliyon; 2023 Nov; 9(11):e22138. PubMed ID: 38045158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
    Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
    Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome.
    Tao W; Gan T; Guo M; Xu Y; Zhong J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
    Welch SR; Guerrero LW; Chakrabarti AK; McMullan LK; Flint M; Bluemling GR; Painter GR; Nichol ST; Spiropoulou CF; Albariño CG
    Antiviral Res; 2016 Dec; 136():9-18. PubMed ID: 27771389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication.
    Edwards MR; Pietzsch C; Vausselin T; Shaw ML; Bukreyev A; Basler CF
    ACS Infect Dis; 2015 Aug; 1(8):380-7. PubMed ID: 26284260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
    Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
    J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
    Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
    J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.
    Wang Z; Li J; Fu Y; Zhao Z; Zhang C; Li N; Li J; Cheng H; Jin X; Lu B; Guo Z; Qian J; Liu L
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
    Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola.
    Nasution MAF; Toepak EP; Alkaff AH; Tambunan USF
    BMC Bioinformatics; 2018 Nov; 19(Suppl 14):419. PubMed ID: 30453886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System.
    Levine CB; Mire CE; Geisbert TW
    J Virol; 2021 Sep; 95(20):e0064321. PubMed ID: 34379503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.
    Mühlberger E; Weik M; Volchkov VE; Klenk HD; Becker S
    J Virol; 1999 Mar; 73(3):2333-42. PubMed ID: 9971816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Dose Treatment With Vesicular Stomatitis Virus-Based Ebola Virus Vaccine Expressing Ebola Virus-Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease.
    O'Donnell KL; Callison J; Feldmann H; Hoenen T; Marzi A
    J Infect Dis; 2023 Nov; 228(Suppl 7):S677-S681. PubMed ID: 37186162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Life Cycle Modeling Systems as Prediction Tools for a Possible Attenuation of Recombinant Ebola Viruses.
    Bodmer BS; Hoenen T
    Viruses; 2022 May; 14(5):. PubMed ID: 35632785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
    Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
    Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport.
    Takamatsu Y; Yoshikawa T; Kurosu T; Fukushi S; Nagata N; Shimojima M; Ebihara H; Saijo M; Noda T
    J Virol; 2022 Sep; 96(17):e0108322. PubMed ID: 35993739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies.
    Ravichandran S; Khurana S
    EBioMedicine; 2022 Aug; 82():104186. PubMed ID: 35901660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
    Herst CV; Burkholz S; Sidney J; Sette A; Harris PE; Massey S; Brasel T; Cunha-Neto E; Rosa DS; Chao WCH; Carback R; Hodge T; Wang L; Ciotlos S; Lloyd P; Rubsamen R
    Vaccine; 2020 Jun; 38(28):4464-4475. PubMed ID: 32418793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.